182 related articles for article (PubMed ID: 11981731)
1. The role of serum antibodies in the protection against rotavirus disease: an overview.
Jiang B; Gentsch JR; Glass RI
Clin Infect Dis; 2002 May; 34(10):1351-61. PubMed ID: 11981731
[TBL] [Abstract][Full Text] [Related]
2. Natural immunity to rotavirus infection in children.
Malik J; Bhan MK; Ray P
Indian J Biochem Biophys; 2008 Aug; 45(4):219-28. PubMed ID: 18788471
[TBL] [Abstract][Full Text] [Related]
3. Systemic and intestinal antibody responses to NSP4 enterotoxin of Wa human rotavirus in a gnotobiotic pig model of human rotavirus disease.
Iosef C; Chang KO; Azevedo MS; Saif LJ
J Med Virol; 2002 Sep; 68(1):119-28. PubMed ID: 12210439
[TBL] [Abstract][Full Text] [Related]
4. Immunity and correlates of protection for rotavirus vaccines.
Franco MA; Angel J; Greenberg HB
Vaccine; 2006 Apr; 24(15):2718-31. PubMed ID: 16446014
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of natural rotavirus infection.
Velázquez FR
Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S54-6. PubMed ID: 19252424
[TBL] [Abstract][Full Text] [Related]
6. Rotavirus vaccines: how they work or don't work.
Ward RL
Expert Rev Mol Med; 2008 Feb; 10():e5. PubMed ID: 18267049
[TBL] [Abstract][Full Text] [Related]
7. Discovery of rotavirus: Implications for child health.
Bishop R
J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S81-5. PubMed ID: 19799704
[TBL] [Abstract][Full Text] [Related]
8. Mucosal and systemic antibody responses and protection induced by a prime/boost rotavirus-DNA vaccine in a gnotobiotic pig model.
Yuan L; Azevedo MS; Gonzalez AM; Jeong KI; Van Nguyen T; Lewis P; Iosef C; Herrmann JE; Saif LJ
Vaccine; 2005 Jun; 23(30):3925-36. PubMed ID: 15917114
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of protection against rotavirus infection and disease.
Ward R
Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S57-9. PubMed ID: 19252425
[TBL] [Abstract][Full Text] [Related]
10. Development of candidate rotavirus vaccines derived from neonatal strains in India.
Glass RI; Bhan MK; Ray P; Bahl R; Parashar UD; Greenberg H; Rao CD; Bhandari N; Maldonado Y; Ward RL; Bernstein DI; Gentsch JR
J Infect Dis; 2005 Sep; 192 Suppl 1():S30-5. PubMed ID: 16088802
[TBL] [Abstract][Full Text] [Related]
11. Inactivated rotavirus vaccines: a priority for accelerated vaccine development.
Jiang B; Gentsch JR; Glass RI
Vaccine; 2008 Dec; 26(52):6754-8. PubMed ID: 18951937
[TBL] [Abstract][Full Text] [Related]
12. Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield), correlate with protection.
González R; Franco M; Sarmiento L; Romero M; Schael IP
J Med Virol; 2005 Aug; 76(4):608-12. PubMed ID: 15977224
[TBL] [Abstract][Full Text] [Related]
13. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
Prescrire Int; 2007 Feb; 16(87):3-6. PubMed ID: 17323513
[TBL] [Abstract][Full Text] [Related]
14. Global impact of rotavirus vaccines.
Tate JE; Patel MM; Steele AD; Gentsch JR; Payne DC; Cortese MM; Nakagomi O; Cunliffe NA; Jiang B; Neuzil KM; de Oliveira LH; Glass RI; Parashar UD
Expert Rev Vaccines; 2010 Apr; 9(4):395-407. PubMed ID: 20370550
[TBL] [Abstract][Full Text] [Related]
15. A review of rotavirus infection in and vaccination of human immunodeficiency virus-infected children.
Steele AD; Cunliffe N; Tumbo J; Madhi SA; De Vos B; Bouckenooghe A
J Infect Dis; 2009 Nov; 200 Suppl 1():S57-62. PubMed ID: 19817615
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
[TBL] [Abstract][Full Text] [Related]
17. [Impact of rotavirus vaccines in developing countries].
Delacour H
Med Trop (Mars); 2009 Aug; 69(4):327-32. PubMed ID: 19725379
[TBL] [Abstract][Full Text] [Related]
18. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
[TBL] [Abstract][Full Text] [Related]
19. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus vaccines for the developing world.
O'Ryan ML; Hermosilla G; Osorio G
Curr Opin Infect Dis; 2009 Oct; 22(5):483-9. PubMed ID: 19623063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
